Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis.

The article focuses on determining the etiology of infection in patients from the Ubon-Sepsis study, categorizing bacteremias and non-bacteremic cases of melioidosis, along with identifying culture-negative cases. Topics include the methodology of metabolomics analysis conducted by Metabolon, Inc., involving sample preparation, chromatography, mass spectrometry, and quality control procedures to analyze plasma samples obtained from study participants.